nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—prostate cancer	0.305	0.703	CbGaD
Zaleplon—AOX1—Ethinyl Estradiol—prostate cancer	0.0927	0.258	CbGbCtD
Zaleplon—CYP3A5—prostate cancer	0.0898	0.207	CbGaD
Zaleplon—AOX1—Estradiol—prostate cancer	0.0597	0.166	CbGbCtD
Zaleplon—CYP3A4—prostate cancer	0.0389	0.0897	CbGaD
Zaleplon—CYP3A5—Flutamide—prostate cancer	0.0218	0.0606	CbGbCtD
Zaleplon—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0195	0.0543	CbGbCtD
Zaleplon—CYP3A5—Cabazitaxel—prostate cancer	0.0161	0.0448	CbGbCtD
Zaleplon—CYP3A5—Estrone—prostate cancer	0.0157	0.0438	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.012	0.0335	CbGbCtD
Zaleplon—CYP3A7—Estradiol—prostate cancer	0.012	0.0335	CbGbCtD
Zaleplon—CYP3A4—Bicalutamide—prostate cancer	0.0102	0.0285	CbGbCtD
Zaleplon—CYP3A4—Estramustine—prostate cancer	0.00952	0.0265	CbGbCtD
Zaleplon—CYP3A5—Estradiol—prostate cancer	0.00903	0.0252	CbGbCtD
Zaleplon—CYP3A4—Flutamide—prostate cancer	0.00848	0.0236	CbGbCtD
Zaleplon—CYP3A4—Abiraterone—prostate cancer	0.00848	0.0236	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00719	0.02	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—prostate cancer	0.00719	0.02	CbGbCtD
Zaleplon—CYP3A4—Cabazitaxel—prostate cancer	0.00628	0.0175	CbGbCtD
Zaleplon—CYP3A4—Estrone—prostate cancer	0.00613	0.0171	CbGbCtD
Zaleplon—CYP3A5—Etoposide—prostate cancer	0.0059	0.0164	CbGbCtD
Zaleplon—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00547	0.0152	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—prostate cancer	0.0054	0.015	CbGbCtD
Zaleplon—CYP3A4—Conjugated Estrogens—prostate cancer	0.00401	0.0112	CbGbCtD
Zaleplon—CYP3A4—Mitoxantrone—prostate cancer	0.00365	0.0102	CbGbCtD
Zaleplon—CYP3A4—Estradiol—prostate cancer	0.00352	0.00981	CbGbCtD
Zaleplon—CYP3A4—Prednisone—prostate cancer	0.00303	0.00844	CbGbCtD
Zaleplon—CYP3A4—Etoposide—prostate cancer	0.0023	0.00641	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—prostate cancer	0.0021	0.00586	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—prostate cancer	0.00157	0.00437	CbGbCtD
Zaleplon—CYP3A4—urine—prostate cancer	0.000644	0.0883	CbGeAlD
Zaleplon—AOX1—prostate gland—prostate cancer	0.000583	0.0798	CbGeAlD
Zaleplon—TSPO—prostate gland—prostate cancer	0.000498	0.0682	CbGeAlD
Zaleplon—AOX1—seminal vesicle—prostate cancer	0.000493	0.0675	CbGeAlD
Zaleplon—GABRB3—prostate gland—prostate cancer	0.000452	0.0619	CbGeAlD
Zaleplon—TSPO—seminal vesicle—prostate cancer	0.000421	0.0577	CbGeAlD
Zaleplon—AOX1—renal system—prostate cancer	0.000397	0.0544	CbGeAlD
Zaleplon—AOX1—urethra—prostate cancer	0.00039	0.0534	CbGeAlD
Zaleplon—TSPO—epithelium—prostate cancer	0.000366	0.0501	CbGeAlD
Zaleplon—TSPO—renal system—prostate cancer	0.000339	0.0465	CbGeAlD
Zaleplon—TSPO—urethra—prostate cancer	0.000333	0.0456	CbGeAlD
Zaleplon—CYP3A5—prostate gland—prostate cancer	0.000308	0.0422	CbGeAlD
Zaleplon—GABRB2—testis—prostate cancer	0.000259	0.0355	CbGeAlD
Zaleplon—AOX1—testis—prostate cancer	0.000257	0.0352	CbGeAlD
Zaleplon—TSPO—bone marrow—prostate cancer	0.000256	0.0351	CbGeAlD
Zaleplon—TSPO—testis—prostate cancer	0.000219	0.03	CbGeAlD
Zaleplon—CYP3A5—renal system—prostate cancer	0.00021	0.0288	CbGeAlD
Zaleplon—GABRB3—testis—prostate cancer	0.000199	0.0273	CbGeAlD
Zaleplon—AOX1—lymph node—prostate cancer	0.000186	0.0255	CbGeAlD
Zaleplon—GABRA2—lymph node—prostate cancer	0.000172	0.0235	CbGeAlD
Zaleplon—TSPO—lymph node—prostate cancer	0.000159	0.0218	CbGeAlD
Zaleplon—CYP3A4—renal system—prostate cancer	0.000158	0.0216	CbGeAlD
Zaleplon—Pneumonia—Doxorubicin—prostate cancer	2.8e-05	0.000187	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—prostate cancer	2.8e-05	0.000187	CcSEcCtD
Zaleplon—Shock—Docetaxel—prostate cancer	2.8e-05	0.000187	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—prostate cancer	2.79e-05	0.000187	CcSEcCtD
Zaleplon—Ill-defined disorder—Prednisone—prostate cancer	2.79e-05	0.000187	CcSEcCtD
Zaleplon—Rash—Estradiol—prostate cancer	2.79e-05	0.000186	CcSEcCtD
Zaleplon—Dermatitis—Estradiol—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Zaleplon—Anaemia—Prednisone—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Zaleplon—Confusional state—Capecitabine—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Zaleplon—Headache—Estradiol—prostate cancer	2.77e-05	0.000185	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—prostate cancer	2.77e-05	0.000185	CcSEcCtD
Zaleplon—Agitation—Prednisone—prostate cancer	2.77e-05	0.000185	CcSEcCtD
Zaleplon—Oedema—Capecitabine—prostate cancer	2.76e-05	0.000184	CcSEcCtD
Zaleplon—Angioedema—Prednisone—prostate cancer	2.75e-05	0.000184	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—prostate cancer	2.73e-05	0.000183	CcSEcCtD
Zaleplon—Urticaria—Etoposide—prostate cancer	2.72e-05	0.000182	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—prostate cancer	2.72e-05	0.000182	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Malaise—Prednisone—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Shock—Capecitabine—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—prostate cancer	2.71e-05	0.000181	CcSEcCtD
Zaleplon—Nervous system disorder—Capecitabine—prostate cancer	2.7e-05	0.000181	CcSEcCtD
Zaleplon—Vertigo—Prednisone—prostate cancer	2.7e-05	0.000181	CcSEcCtD
Zaleplon—Syncope—Prednisone—prostate cancer	2.7e-05	0.00018	CcSEcCtD
Zaleplon—Tachycardia—Capecitabine—prostate cancer	2.69e-05	0.00018	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—prostate cancer	2.69e-05	0.00018	CcSEcCtD
Zaleplon—Skin disorder—Capecitabine—prostate cancer	2.68e-05	0.000179	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—prostate cancer	2.67e-05	0.000179	CcSEcCtD
Zaleplon—Hyperhidrosis—Capecitabine—prostate cancer	2.67e-05	0.000178	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—prostate cancer	2.64e-05	0.000177	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—prostate cancer	2.64e-05	0.000176	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—prostate cancer	2.63e-05	0.000176	CcSEcCtD
Zaleplon—Anorexia—Capecitabine—prostate cancer	2.63e-05	0.000176	CcSEcCtD
Zaleplon—Nausea—Estradiol—prostate cancer	2.63e-05	0.000175	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—prostate cancer	2.61e-05	0.000174	CcSEcCtD
Zaleplon—Hypertension—Prednisone—prostate cancer	2.6e-05	0.000174	CcSEcCtD
Zaleplon—Rash—Mitoxantrone—prostate cancer	2.6e-05	0.000174	CcSEcCtD
Zaleplon—Dermatitis—Mitoxantrone—prostate cancer	2.59e-05	0.000173	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.59e-05	0.000173	CcSEcCtD
Zaleplon—Headache—Mitoxantrone—prostate cancer	2.58e-05	0.000172	CcSEcCtD
Zaleplon—Hypotension—Capecitabine—prostate cancer	2.58e-05	0.000172	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—prostate cancer	2.58e-05	0.000172	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—prostate cancer	2.56e-05	0.000171	CcSEcCtD
Zaleplon—Myalgia—Prednisone—prostate cancer	2.56e-05	0.000171	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—prostate cancer	2.56e-05	0.000171	CcSEcCtD
Zaleplon—Anxiety—Prednisone—prostate cancer	2.55e-05	0.000171	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.54e-05	0.00017	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—prostate cancer	2.54e-05	0.00017	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—prostate cancer	2.53e-05	0.000169	CcSEcCtD
Zaleplon—Discomfort—Prednisone—prostate cancer	2.53e-05	0.000169	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—prostate cancer	2.53e-05	0.000169	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—prostate cancer	2.52e-05	0.000168	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.51e-05	0.000168	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—prostate cancer	2.51e-05	0.000168	CcSEcCtD
Zaleplon—Insomnia—Capecitabine—prostate cancer	2.49e-05	0.000167	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—prostate cancer	2.49e-05	0.000166	CcSEcCtD
Zaleplon—Paraesthesia—Capecitabine—prostate cancer	2.48e-05	0.000165	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—prostate cancer	2.48e-05	0.000165	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—prostate cancer	2.46e-05	0.000165	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Zaleplon—Asthenia—Etoposide—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Zaleplon—Dyspnoea—Capecitabine—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Zaleplon—Oedema—Prednisone—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Zaleplon—Nausea—Mitoxantrone—prostate cancer	2.45e-05	0.000164	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—prostate cancer	2.44e-05	0.000163	CcSEcCtD
Zaleplon—Constipation—Docetaxel—prostate cancer	2.43e-05	0.000163	CcSEcCtD
Zaleplon—Pain—Docetaxel—prostate cancer	2.43e-05	0.000163	CcSEcCtD
Zaleplon—Dyspepsia—Capecitabine—prostate cancer	2.43e-05	0.000162	CcSEcCtD
Zaleplon—Chills—Epirubicin—prostate cancer	2.43e-05	0.000162	CcSEcCtD
Zaleplon—Pruritus—Etoposide—prostate cancer	2.42e-05	0.000162	CcSEcCtD
Zaleplon—Shock—Prednisone—prostate cancer	2.42e-05	0.000161	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—prostate cancer	2.41e-05	0.000161	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—prostate cancer	2.41e-05	0.000161	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—prostate cancer	2.4e-05	0.00016	CcSEcCtD
Zaleplon—Decreased appetite—Capecitabine—prostate cancer	2.4e-05	0.00016	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—prostate cancer	2.39e-05	0.00016	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—prostate cancer	2.39e-05	0.000159	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Capecitabine—prostate cancer	2.38e-05	0.000159	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—prostate cancer	2.37e-05	0.000159	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—prostate cancer	2.37e-05	0.000158	CcSEcCtD
Zaleplon—Pain—Capecitabine—prostate cancer	2.36e-05	0.000158	CcSEcCtD
Zaleplon—Constipation—Capecitabine—prostate cancer	2.36e-05	0.000158	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—prostate cancer	2.35e-05	0.000157	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—prostate cancer	2.35e-05	0.000157	CcSEcCtD
Zaleplon—Anorexia—Prednisone—prostate cancer	2.34e-05	0.000156	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—prostate cancer	2.34e-05	0.000156	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—prostate cancer	2.33e-05	0.000156	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—prostate cancer	2.33e-05	0.000156	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—prostate cancer	2.32e-05	0.000155	CcSEcCtD
Zaleplon—Tension—Epirubicin—prostate cancer	2.31e-05	0.000154	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—prostate cancer	2.3e-05	0.000154	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—prostate cancer	2.29e-05	0.000153	CcSEcCtD
Zaleplon—Back pain—Epirubicin—prostate cancer	2.28e-05	0.000152	CcSEcCtD
Zaleplon—Feeling abnormal—Capecitabine—prostate cancer	2.27e-05	0.000152	CcSEcCtD
Zaleplon—Dizziness—Etoposide—prostate cancer	2.27e-05	0.000151	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—prostate cancer	2.26e-05	0.000151	CcSEcCtD
Zaleplon—Gastrointestinal pain—Capecitabine—prostate cancer	2.25e-05	0.000151	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—prostate cancer	2.25e-05	0.00015	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—prostate cancer	2.25e-05	0.00015	CcSEcCtD
Zaleplon—Chills—Doxorubicin—prostate cancer	2.24e-05	0.00015	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—prostate cancer	2.24e-05	0.00015	CcSEcCtD
Zaleplon—Insomnia—Prednisone—prostate cancer	2.22e-05	0.000148	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—prostate cancer	2.21e-05	0.000148	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—prostate cancer	2.21e-05	0.000147	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—prostate cancer	2.19e-05	0.000146	CcSEcCtD
Zaleplon—Urticaria—Capecitabine—prostate cancer	2.19e-05	0.000146	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—prostate cancer	2.18e-05	0.000146	CcSEcCtD
Zaleplon—Abdominal pain—Capecitabine—prostate cancer	2.18e-05	0.000146	CcSEcCtD
Zaleplon—Body temperature increased—Capecitabine—prostate cancer	2.18e-05	0.000146	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—prostate cancer	2.18e-05	0.000146	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—prostate cancer	2.18e-05	0.000145	CcSEcCtD
Zaleplon—Agitation—Epirubicin—prostate cancer	2.16e-05	0.000145	CcSEcCtD
Zaleplon—Dyspepsia—Prednisone—prostate cancer	2.16e-05	0.000144	CcSEcCtD
Zaleplon—Rash—Etoposide—prostate cancer	2.16e-05	0.000144	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—prostate cancer	2.16e-05	0.000144	CcSEcCtD
Zaleplon—Headache—Etoposide—prostate cancer	2.15e-05	0.000143	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—prostate cancer	2.15e-05	0.000143	CcSEcCtD
Zaleplon—Tension—Doxorubicin—prostate cancer	2.14e-05	0.000143	CcSEcCtD
Zaleplon—Decreased appetite—Prednisone—prostate cancer	2.13e-05	0.000143	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—prostate cancer	2.13e-05	0.000143	CcSEcCtD
Zaleplon—Malaise—Epirubicin—prostate cancer	2.12e-05	0.000142	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—prostate cancer	2.11e-05	0.000141	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—prostate cancer	2.11e-05	0.000141	CcSEcCtD
Zaleplon—Syncope—Epirubicin—prostate cancer	2.11e-05	0.000141	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—prostate cancer	2.11e-05	0.000141	CcSEcCtD
Zaleplon—Constipation—Prednisone—prostate cancer	2.1e-05	0.00014	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—prostate cancer	2.08e-05	0.000139	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—prostate cancer	2.07e-05	0.000138	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—prostate cancer	2.04e-05	0.000137	CcSEcCtD
Zaleplon—Nausea—Etoposide—prostate cancer	2.04e-05	0.000136	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—prostate cancer	2.03e-05	0.000136	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisone—prostate cancer	2.02e-05	0.000135	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—prostate cancer	2.02e-05	0.000135	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—prostate cancer	2.01e-05	0.000135	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—prostate cancer	2.01e-05	0.000135	CcSEcCtD
Zaleplon—Gastrointestinal pain—Prednisone—prostate cancer	2.01e-05	0.000134	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—prostate cancer	2e-05	0.000134	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—prostate cancer	2e-05	0.000134	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—prostate cancer	2e-05	0.000134	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—prostate cancer	2e-05	0.000134	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—prostate cancer	2e-05	0.000133	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.99e-05	0.000133	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—prostate cancer	1.98e-05	0.000132	CcSEcCtD
Zaleplon—Asthenia—Capecitabine—prostate cancer	1.98e-05	0.000132	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—prostate cancer	1.95e-05	0.000131	CcSEcCtD
Zaleplon—Urticaria—Prednisone—prostate cancer	1.95e-05	0.00013	CcSEcCtD
Zaleplon—Pruritus—Capecitabine—prostate cancer	1.95e-05	0.00013	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—prostate cancer	1.94e-05	0.00013	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—prostate cancer	1.94e-05	0.00013	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—prostate cancer	1.94e-05	0.000129	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—prostate cancer	1.92e-05	0.000129	CcSEcCtD
Zaleplon—Oedema—Epirubicin—prostate cancer	1.92e-05	0.000128	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—prostate cancer	1.92e-05	0.000128	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—prostate cancer	1.91e-05	0.000128	CcSEcCtD
Zaleplon—Shock—Epirubicin—prostate cancer	1.89e-05	0.000126	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—prostate cancer	1.88e-05	0.000126	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—prostate cancer	1.88e-05	0.000126	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—prostate cancer	1.88e-05	0.000126	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—prostate cancer	1.87e-05	0.000125	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—prostate cancer	1.87e-05	0.000125	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—prostate cancer	1.86e-05	0.000124	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—prostate cancer	1.85e-05	0.000124	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—prostate cancer	1.85e-05	0.000124	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—prostate cancer	1.85e-05	0.000124	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—prostate cancer	1.85e-05	0.000123	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.84e-05	0.000123	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—prostate cancer	1.83e-05	0.000122	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—prostate cancer	1.83e-05	0.000122	CcSEcCtD
Zaleplon—Dizziness—Capecitabine—prostate cancer	1.82e-05	0.000122	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—prostate cancer	1.81e-05	0.000121	CcSEcCtD
Zaleplon—Rash—Docetaxel—prostate cancer	1.8e-05	0.00012	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Zaleplon—Headache—Docetaxel—prostate cancer	1.78e-05	0.000119	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—prostate cancer	1.78e-05	0.000119	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—prostate cancer	1.78e-05	0.000119	CcSEcCtD
Zaleplon—Asthenia—Prednisone—prostate cancer	1.76e-05	0.000118	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.75e-05	0.000117	CcSEcCtD
Zaleplon—Shock—Doxorubicin—prostate cancer	1.75e-05	0.000117	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—prostate cancer	1.74e-05	0.000116	CcSEcCtD
Zaleplon—Rash—Capecitabine—prostate cancer	1.74e-05	0.000116	CcSEcCtD
Zaleplon—Pruritus—Prednisone—prostate cancer	1.74e-05	0.000116	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—prostate cancer	1.74e-05	0.000116	CcSEcCtD
Zaleplon—Dermatitis—Capecitabine—prostate cancer	1.74e-05	0.000116	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—prostate cancer	1.73e-05	0.000116	CcSEcCtD
Zaleplon—Headache—Capecitabine—prostate cancer	1.73e-05	0.000115	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—prostate cancer	1.73e-05	0.000115	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—prostate cancer	1.72e-05	0.000115	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—prostate cancer	1.72e-05	0.000115	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—prostate cancer	1.71e-05	0.000114	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—prostate cancer	1.71e-05	0.000114	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—prostate cancer	1.69e-05	0.000113	CcSEcCtD
Zaleplon—Nausea—Docetaxel—prostate cancer	1.69e-05	0.000113	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—prostate cancer	1.69e-05	0.000113	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—prostate cancer	1.67e-05	0.000112	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—prostate cancer	1.66e-05	0.000111	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—prostate cancer	1.66e-05	0.000111	CcSEcCtD
Zaleplon—Constipation—Epirubicin—prostate cancer	1.64e-05	0.00011	CcSEcCtD
Zaleplon—Pain—Epirubicin—prostate cancer	1.64e-05	0.00011	CcSEcCtD
Zaleplon—Nausea—Capecitabine—prostate cancer	1.64e-05	0.000109	CcSEcCtD
Zaleplon—Dizziness—Prednisone—prostate cancer	1.62e-05	0.000109	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.62e-05	0.000108	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—prostate cancer	1.61e-05	0.000107	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—prostate cancer	1.6e-05	0.000107	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—prostate cancer	1.58e-05	0.000106	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—prostate cancer	1.58e-05	0.000106	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—prostate cancer	1.58e-05	0.000106	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—prostate cancer	1.57e-05	0.000105	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—prostate cancer	1.56e-05	0.000105	CcSEcCtD
Zaleplon—Rash—Prednisone—prostate cancer	1.55e-05	0.000103	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—prostate cancer	1.55e-05	0.000103	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—prostate cancer	1.54e-05	0.000103	CcSEcCtD
Zaleplon—Headache—Prednisone—prostate cancer	1.54e-05	0.000103	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.53e-05	0.000103	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—prostate cancer	1.53e-05	0.000102	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—prostate cancer	1.52e-05	0.000102	CcSEcCtD
Zaleplon—Pain—Doxorubicin—prostate cancer	1.52e-05	0.000102	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—prostate cancer	1.52e-05	0.000101	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—prostate cancer	1.52e-05	0.000101	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—prostate cancer	1.46e-05	9.79e-05	CcSEcCtD
Zaleplon—Nausea—Prednisone—prostate cancer	1.46e-05	9.75e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—prostate cancer	1.45e-05	9.71e-05	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—prostate cancer	1.41e-05	9.44e-05	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—prostate cancer	1.4e-05	9.39e-05	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—prostate cancer	1.4e-05	9.39e-05	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—prostate cancer	1.38e-05	9.21e-05	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—prostate cancer	1.36e-05	9.08e-05	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—prostate cancer	1.27e-05	8.52e-05	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—prostate cancer	1.27e-05	8.49e-05	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—prostate cancer	1.26e-05	8.4e-05	CcSEcCtD
Zaleplon—Rash—Epirubicin—prostate cancer	1.21e-05	8.09e-05	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—prostate cancer	1.21e-05	8.09e-05	CcSEcCtD
Zaleplon—Headache—Epirubicin—prostate cancer	1.2e-05	8.04e-05	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—prostate cancer	1.18e-05	7.85e-05	CcSEcCtD
Zaleplon—Nausea—Epirubicin—prostate cancer	1.14e-05	7.62e-05	CcSEcCtD
Zaleplon—Rash—Doxorubicin—prostate cancer	1.12e-05	7.49e-05	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—prostate cancer	1.12e-05	7.48e-05	CcSEcCtD
Zaleplon—Headache—Doxorubicin—prostate cancer	1.11e-05	7.44e-05	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—prostate cancer	1.06e-05	7.05e-05	CcSEcCtD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.93e-06	0.000157	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LDHB—prostate cancer	7.87e-06	0.000156	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAV1—prostate cancer	7.87e-06	0.000156	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SULT2A1—prostate cancer	7.83e-06	0.000155	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MED12—prostate cancer	7.7e-06	0.000152	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNG5—prostate cancer	7.64e-06	0.000151	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAP2K1—prostate cancer	7.58e-06	0.00015	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—prostate cancer	7.53e-06	0.000149	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PDHA1—prostate cancer	7.47e-06	0.000148	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UCP3—prostate cancer	7.47e-06	0.000148	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA3—prostate cancer	7.47e-06	0.000148	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TCN2—prostate cancer	7.47e-06	0.000148	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—prostate cancer	7.45e-06	0.000147	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA3—prostate cancer	7.36e-06	0.000146	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF2—prostate cancer	7.21e-06	0.000143	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—prostate cancer	7.17e-06	0.000142	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD3B1—prostate cancer	7.12e-06	0.000141	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC22A3—prostate cancer	7.12e-06	0.000141	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—prostate cancer	7.11e-06	0.000141	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HPGDS—prostate cancer	7.02e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2C19—prostate cancer	6.98e-06	0.000138	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.93e-06	0.000137	CbGpPWpGaD
Zaleplon—AOX1—Disease—JAK2—prostate cancer	6.91e-06	0.000137	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA4—prostate cancer	6.83e-06	0.000135	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TBXAS1—prostate cancer	6.83e-06	0.000135	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ACHE—prostate cancer	6.81e-06	0.000135	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—prostate cancer	6.81e-06	0.000135	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INS—prostate cancer	6.79e-06	0.000134	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—prostate cancer	6.74e-06	0.000133	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2A6—prostate cancer	6.73e-06	0.000133	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA2—prostate cancer	6.65e-06	0.000132	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CREBBP—prostate cancer	6.65e-06	0.000132	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—prostate cancer	6.65e-06	0.000132	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SULT1A1—prostate cancer	6.57e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG5—prostate cancer	6.57e-06	0.00013	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—prostate cancer	6.56e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C3—prostate cancer	6.55e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PRKACB—prostate cancer	6.51e-06	0.000129	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GRHL1—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TST—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSAT1—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CSAD—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CBR1—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADI1—prostate cancer	6.5e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP17A1—prostate cancer	6.45e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA1—prostate cancer	6.42e-06	0.000127	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD3B2—prostate cancer	6.35e-06	0.000126	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAT2—prostate cancer	6.35e-06	0.000126	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTO1—prostate cancer	6.35e-06	0.000126	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—prostate cancer	6.3e-06	0.000125	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—prostate cancer	6.16e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA2—prostate cancer	6.14e-06	0.000121	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCB2—prostate cancer	6.09e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LRP2—prostate cancer	6.09e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2C18—prostate cancer	6.09e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GRHPR—prostate cancer	6.04e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGT2B15—prostate cancer	6.04e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CKMT2—prostate cancer	6.04e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGT2B17—prostate cancer	6.04e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—P4HB—prostate cancer	5.97e-06	0.000118	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—prostate cancer	5.95e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC5A5—prostate cancer	5.86e-06	0.000116	CbGpPWpGaD
Zaleplon—AOX1—Disease—CTNNB1—prostate cancer	5.82e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC22A1—prostate cancer	5.81e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2E1—prostate cancer	5.72e-06	0.000113	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT2B1—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MBTPS1—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM3—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PGAM2—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAGLU—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RFK—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AOX1—prostate cancer	5.68e-06	0.000112	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—prostate cancer	5.67e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NQO1—prostate cancer	5.66e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SULT2A1—prostate cancer	5.66e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TH—prostate cancer	5.58e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MED12—prostate cancer	5.57e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNG5—prostate cancer	5.52e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP3A4—prostate cancer	5.52e-06	0.000109	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—prostate cancer	5.49e-06	0.000109	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—prostate cancer	5.44e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1B1—prostate cancer	5.42e-06	0.000107	CbGpPWpGaD
Zaleplon—AOX1—Disease—EP300—prostate cancer	5.41e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP3A43—prostate cancer	5.39e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AMACR—prostate cancer	5.39e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DEGS1—prostate cancer	5.39e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SRD5A2—prostate cancer	5.39e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAT1—prostate cancer	5.39e-06	0.000107	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA3—prostate cancer	5.32e-06	0.000105	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—prostate cancer	5.26e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GGT1—prostate cancer	5.25e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA1—prostate cancer	5.18e-06	0.000102	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B1—prostate cancer	5.14e-06	0.000102	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP19A1—prostate cancer	5.1e-06	0.000101	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HPGDS—prostate cancer	5.07e-06	0.0001	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—prostate cancer	5.07e-06	0.0001	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2C19—prostate cancer	5.04e-06	9.98e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RXRA—prostate cancer	4.92e-06	9.74e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACHE—prostate cancer	4.92e-06	9.74e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—prostate cancer	4.92e-06	9.74e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A6—prostate cancer	4.87e-06	9.62e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—prostate cancer	4.75e-06	9.39e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—COMT—prostate cancer	4.74e-06	9.38e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C3—prostate cancer	4.73e-06	9.36e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—prostate cancer	4.72e-06	9.34e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—prostate cancer	4.71e-06	9.32e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PRKACB—prostate cancer	4.71e-06	9.31e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—prostate cancer	4.7e-06	9.3e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP17A1—prostate cancer	4.66e-06	9.22e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ITPR1—prostate cancer	4.64e-06	9.19e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—prostate cancer	4.61e-06	9.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPGD—prostate cancer	4.58e-06	9.06e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.58e-06	9.06e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—EP300—prostate cancer	4.53e-06	8.96e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA2—prostate cancer	4.44e-06	8.78e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMS—prostate cancer	4.39e-06	8.68e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—prostate cancer	4.35e-06	8.61e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—prostate cancer	4.34e-06	8.58e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.31e-06	8.52e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPL—prostate cancer	4.26e-06	8.42e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC5A5—prostate cancer	4.24e-06	8.38e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.19e-06	8.29e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTAP—prostate cancer	4.19e-06	8.29e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2E1—prostate cancer	4.14e-06	8.18e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—prostate cancer	4.11e-06	8.13e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NQO1—prostate cancer	4.09e-06	8.09e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.08e-06	8.07e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.08e-06	8.07e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ERCC2—prostate cancer	4.08e-06	8.07e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TH—prostate cancer	4.03e-06	7.97e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—prostate cancer	4e-06	7.91e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP3A4—prostate cancer	3.99e-06	7.89e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1B1—prostate cancer	3.92e-06	7.76e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACSL4—prostate cancer	3.89e-06	7.7e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.89e-06	7.7e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—prostate cancer	3.83e-06	7.58e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GGT1—prostate cancer	3.8e-06	7.51e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARA—prostate cancer	3.76e-06	7.44e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA1—prostate cancer	3.74e-06	7.4e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ARG2—prostate cancer	3.73e-06	7.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UMPS—prostate cancer	3.73e-06	7.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PHGDH—prostate cancer	3.73e-06	7.39e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP19A1—prostate cancer	3.69e-06	7.29e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LDHB—prostate cancer	3.66e-06	7.24e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.59e-06	7.11e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RXRA—prostate cancer	3.56e-06	7.04e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—prostate cancer	3.54e-06	7.01e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—prostate cancer	3.54e-06	6.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA3—prostate cancer	3.47e-06	6.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UCP3—prostate cancer	3.47e-06	6.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TCN2—prostate cancer	3.47e-06	6.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PDHA1—prostate cancer	3.47e-06	6.87e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—COMT—prostate cancer	3.43e-06	6.78e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—prostate cancer	3.41e-06	6.75e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ITPR1—prostate cancer	3.36e-06	6.64e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—prostate cancer	3.35e-06	6.63e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.31e-06	6.55e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.31e-06	6.55e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—prostate cancer	3.27e-06	6.46e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—prostate cancer	3.22e-06	6.37e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA4—prostate cancer	3.17e-06	6.28e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.17e-06	6.28e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMS—prostate cancer	3.17e-06	6.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—prostate cancer	3.13e-06	6.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA2—prostate cancer	3.09e-06	6.12e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPL—prostate cancer	3.08e-06	6.09e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.06e-06	6.04e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG5—prostate cancer	3.06e-06	6.04e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INS—prostate cancer	3.05e-06	6.03e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CREBBP—prostate cancer	2.99e-06	5.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA1—prostate cancer	2.98e-06	5.9e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.97e-06	5.88e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.95e-06	5.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTO1—prostate cancer	2.95e-06	5.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAT2—prostate cancer	2.95e-06	5.84e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ERCC2—prostate cancer	2.95e-06	5.83e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.83e-06	5.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCB2—prostate cancer	2.83e-06	5.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LRP2—prostate cancer	2.83e-06	5.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.83e-06	5.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—P4HB—prostate cancer	2.77e-06	5.49e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—prostate cancer	2.77e-06	5.48e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—prostate cancer	2.74e-06	5.41e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARA—prostate cancer	2.72e-06	5.38e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.7e-06	5.34e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—prostate cancer	2.67e-06	5.29e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.63e-06	5.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MED12—prostate cancer	2.59e-06	5.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNG5—prostate cancer	2.57e-06	5.08e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—prostate cancer	2.56e-06	5.06e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA3—prostate cancer	2.47e-06	4.89e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.47e-06	4.88e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—prostate cancer	2.44e-06	4.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPGDS—prostate cancer	2.36e-06	4.67e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.34e-06	4.64e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.33e-06	4.61e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACHE—prostate cancer	2.29e-06	4.53e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—prostate cancer	2.29e-06	4.53e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.26e-06	4.47e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INS—prostate cancer	2.2e-06	4.36e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.2e-06	4.35e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PRKACB—prostate cancer	2.19e-06	4.33e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.17e-06	4.28e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CREBBP—prostate cancer	2.16e-06	4.27e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—prostate cancer	2.13e-06	4.22e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA2—prostate cancer	2.06e-06	4.08e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.05e-06	4.05e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—EP300—prostate cancer	2.03e-06	4.02e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.97e-06	3.9e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—prostate cancer	1.93e-06	3.82e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.92e-06	3.8e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NQO1—prostate cancer	1.9e-06	3.76e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TH—prostate cancer	1.87e-06	3.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.82e-06	3.61e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.78e-06	3.53e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—prostate cancer	1.77e-06	3.5e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GGT1—prostate cancer	1.77e-06	3.49e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA1—prostate cancer	1.74e-06	3.44e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.71e-06	3.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RXRA—prostate cancer	1.65e-06	3.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COMT—prostate cancer	1.59e-06	3.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—prostate cancer	1.59e-06	3.14e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ITPR1—prostate cancer	1.56e-06	3.09e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—prostate cancer	1.54e-06	3.05e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.5e-06	2.98e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMS—prostate cancer	1.47e-06	2.92e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EP300—prostate cancer	1.47e-06	2.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—prostate cancer	1.46e-06	2.88e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPL—prostate cancer	1.43e-06	2.83e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.38e-06	2.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ERCC2—prostate cancer	1.37e-06	2.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—prostate cancer	1.29e-06	2.55e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARA—prostate cancer	1.26e-06	2.5e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—prostate cancer	1.23e-06	2.43e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—prostate cancer	1.19e-06	2.35e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.09e-06	2.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.08e-06	2.14e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INS—prostate cancer	1.02e-06	2.03e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CREBBP—prostate cancer	1e-06	1.98e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.51e-07	1.88e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—prostate cancer	8.98e-07	1.78e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—prostate cancer	8.88e-07	1.76e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.29e-07	1.64e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—prostate cancer	8.22e-07	1.63e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—prostate cancer	7.17e-07	1.42e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EP300—prostate cancer	6.83e-07	1.35e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.06e-07	1e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—prostate cancer	4.13e-07	8.17e-06	CbGpPWpGaD
